Hepatocellular Carcinoma (HCC): Recent Updates and Evolving Treatment Paradigms - Episode 12

Tremelimumab Plus Durvalumab in Patients With Advanced HCC: The HIMALAYA Study

Dr R. Katie Kelley shares her thoughts on the four-year updated survival and efficacy data from the phase 3 HIMALAYA trial in patients with advanced hepatocellular carcinoma.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    x